Artificial Intelligence

The latest comes for Zebra Medical's HealthMammo algorithm, which helps radiologists pinpoint and prioritize suspicious breast images.

Plus, new CT scanner drapes, Nuance's latest AI Marketplace addition, and several firms raise millions in capital. 

South Korean scientists detailed their new “automatic detection algorithm” in a study published recently in Radiology

“Cina Head,” as the solution is called, aids docs with the automatic detection of hemorrhaging inside of the skull or a clot blocking the flow of blood to the brain, the company said. 

Officials said the algorithm could act as a “robust lung nodule spell-checker” that reduces rad read times while maintaining accuracy. 

MammoScreen, as it’s called, operates by automatically detecting and characterizing suspicious soft tissue lesions and calcifications. 

Top officials from the two groups believe it’s unlikely the FDA can provide assurances of such technology’s safety in imaging care, absent further testing, surveillance and other methods of oversight.

The money comes by way of the European Innovation Council Accelerator and balloons Quantib's fundraising total to almost $13.5 million (USD). 

Stanford University experts call their new neural network “LungNet” and say the system has delivered consistent, fast and accurate interpretation of computed tomography scans.

Deep01 said the lion’s share of the contribution comes by way of electronics manufacturer Asus, with other Taiwan-based firms such as BE Capital also contributing. 

London investment firm MMC Ventures is pitching in the largest share of capital, with additional contributions from Bayer, Seedcamp and InHealth Ventures, Agamon announced Monday. 

The National Cancer Institute model only accounts for colon and breast cancer screenings and represents a roughly 1% increase over pre-COVID-19 estimates.